NOT-EB-24-015: Notice of NIBIB Participation in PA-25-080: "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice of NIBIB Participation in PA-25-080: "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-EB-24-015

Key Dates

Release Date:

October 10, 2024

Related Announcements

October 02, 2024 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See NOFO PA-25-080.

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants that effective October 11, 2024, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate in PA-25-080, "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)", issued by the National Institutes of Health.

The following text has been added to reflect NIBIB’s participation in the NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.286

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Dave Gutekunst, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Division of Interdisciplinary Training
Telephone: 240-789-0004
Email: dave.gutekunst@nih.gov